Biblio
Stem cell comparison: what can we learn clinically from unrelated cord blood transplantation as an alternative stem cell source?. Cytotherapy. 2015.
. Response to Kawedia et al Letter to Editor in Response to the Article by McCune Et Al "Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement". Biol Blood Marrow Transplant. 2020.
Predictors for Autoimmune Cytopenias after Allogeneic Hematopoietic Cell Transplantation in Children. Biol Blood Marrow Transplant. 2019.
. Practice Pattern Changes and Improvements in Hematopoietic Cell Transplantation for Primary Immunodeficiencies. J Allergy Clin Immunol. 2018.
. Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children With Recessive Dystrophic Epidermolysis Bullosa. J Invest Dermatol. 2015.
Metachromatic leukodystrophy and transplantation: remyelination, no cross-correction. Ann Clin Transl Neurol. 2020.
Donor-Host Lineage-Specific Chimerism Monitoring and Analysis in Pediatric Patients Following Allogeneic Stem Cell Transplantation: Influence of Pre-Transplantation Variables and Correlation with Post-Transplant Outcomes. Transplant Cell Ther. 2021.
. Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis. Lancet Haematol. 2015;2(5):e194-203.
. Anti-thymocyte globulin for GVHD: one dose does not fit all. Lancet Haematol. 2020;7(7):e505.
.